Chemotherapeutic options for primary brain tumors

Keyphrases

• Primary Brain Tumor 100%
• Malignant Glioma 60%
• Chemosensitivity 40%
• Chemotherapy 40%
• Glioblastoma multiforme 40%
• Radiation Therapy 40%
• Temozolomide 40%
• Chromosome 1p 40%
• Clinical Trials 20%
• Recent Advances 20%
• Significant Predictors 20%
• National Cancer Institute 20%
• Recent Experience 20%
• Overall Survival 20%
• Improved Survival 20%
• Survival Benefit 20%
• Long-term Survival 20%
• Canada 20%
• Cancer Treatment 20%
• Progression-free Survival 20%
• Clinical Investigation 20%
• Recurrence Rate 20%
• Novel Therapeutics 20%
• Strong Predictor 20%
• European Organizations 20%
• Biological Response Modifiers 20%
• Molecular Targeted Agents 20%
• Molecular Genetic Testing 20%
• Chemotherapy Efficacy 20%
• Medulloblastoma 20%
• Angiogenesis Inhibitors 20%
• Allelic Loss 20%
• Primary Therapy 20%
• Molecular Targeted Therapy 20%

Medicine and Dentistry

• Chromosome 1p 33%
• Primary Central Nervous System Lymphoma 16%
• Chromosome 19q 16%

Neuroscience

• Primary Central Nervous System Lymphoma 20%
• Chromosome 19q 20%